CLASS II ONGOING Device recall · Reported 23 Oct 2019 · FDA Enforcement Report

Cerelink ICP Monitor recalled by Integra LifeSciences

Integra LifeSciences is recalling Cerelink ICP Monitor, distributed in 11 states. The recall was initiated on 12 Sep 2019 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesAll systems
Quantity recalled189

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0124-2020
FDA event ID
83831
Recalling firm
Integra LifeSciences, Plainsboro, NJ
Classification
Class II
Status
Ongoing
Recall initiated
12 Sep 2019
FDA classified
12 Oct 2019
Reported
23 Oct 2019
Type
Voluntary: Firm initiated
Customers notified by
Visit
Reason category
Other Reasons
Device type
Patient Monitors

Timeline

12 Sep 2019Recall initiated by company
12 Oct 2019Classified by FDA+30 days
23 Oct 2019Published in enforcement report+11 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

There is a potential for a progressive decline in observed ICP readings of the monitor during use.

Product as listed by the FDA

Cerelink ICP Monitor, Model Number 826820; intended for use as an interface between compatible strain-gauge type pressure transducers and standard physiological pressure monitoring systems.

Where it was distributed

The products were distributed to the following US states: CA, CO, CT, FL, IN, NY, OK, PA, TX, WI, and WV. The products were distributed to the following foreign countries: Australia, Belgium.

CaliforniaColoradoConnecticutFloridaIndianaNew YorkOklahomaPennsylvaniaTexasWisconsinWest Virginia

Questions about this recall

Why was it recalled?

There is a potential for a progressive decline in observed ICP readings of the monitor during use.

Which lots are affected?

All systems

Where was it sold?

The products were distributed to the following US states: CA, CO, CT, FL, IN, NY, OK, PA, TX, WI, and WV. The products were distributed to the following foreign countries: Australia, Belgium.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Integra LifeSciences

All 246

Other Patient Monitors recalls

All 1,013